NewAmsterdam Pharma, a Biotechnology Company That Aims to Treat Metabolic Diseases, is in ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'NewAmsterdam Pharma, a biotechnology company that aims to treat metabolic diseases, is in talks to go public through a merger with blank-check firm Frazier Lifesciences ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)